Aspire-Lakewood Holdings, Inc.
ASBPW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001847345
No open-market purchases or sales by Aspire-Lakewood Holdings, Inc. insiders were filed in the last 90 days; 29 institutions reported holding it in 13F filings for Q2 2026, worth $145.4K in total; no superinvestor holds it.
Other share classesASBP
Q1 2024 vs. Q4 2023
How the institutions holding Aspire-Lakewood Holdings, Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 37 | 36 | −1 |
| Shares | 8.97M | 8.86M | −105.1K (−1.2%) |
| Value | $590.3K | $299.9K | −$290.4K (−49.2%) |
New holders (3)
Institutions that held Aspire-Lakewood Holdings, Inc. at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Exos Asset Management LLC | 137,000 | $4.12K | 0.00% |
| Clear Street Derivatives LLC | 106,000 | $3.19K | 0.00% |
| First Pacific Advisors, LP | 28,482 | $857 | 0.00% |
Sold out (4)
Institutions that held Aspire-Lakewood Holdings, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Spartan Fund Management Inc. | 187,080 | $11.2K |
| Susquehanna International Group, LLP | 23,803 | $1.43K |
| Bulldog Investors, LLP | 12,500 | $634 |
| Cohanzick Management, LLC | 166,667 | $0 |